Heart procedure safety study aims to reduce blood clot and bleeding risks
NCT ID NCT07361081
Summary
This study looks back at 300 patients who had a procedure to treat an irregular heartbeat (atrial fibrillation). It compares two different ways doctors give a blood-thinning medicine (heparin) during the procedure. The goal is to see which method keeps the patient's blood at the safest thickness level to prevent both dangerous clots and excessive bleeding.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Taiwan University Hospital,
Taipei, 100, Taiwan
Conditions
Explore the condition pages connected to this study.